Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F5VHY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,102
Award facts
- Contract value 100% obligated
- $59,101.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $59,101.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on January 28, 2026, with an ultimate completion date of January 29, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., the parent pharmaceutical distribution company. NURTEC ODT is a migraine treatment medication used within military and federal healthcare systems to address neurological conditions affecting service members and beneficiaries. As a major federal pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contract awards across multiple therapeutic domains, demonstrating its critical role in the Defense Health Agency's medical supply chain and broader military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5VHY?
SPE2DR26F5VHY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F5VHY worth?
The government has obligated $59,102 on SPE2DR26F5VHY.
Is contract SPE2DR26F5VHY an order under another contract?
Yes. SPE2DR26F5VHY is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VHY competed?
The extent of competition for SPE2DR26F5VHY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award